TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN IRAQ: A 17-YEAR EXPERIENCE FROM A SINGLE CENTER
Salma A. Al‐Hadad(University of Baghdad), Anna Maria Testi(Sapienza University of Rome), Ahmed Hatem Sabhan(Baghdad Medical City), Hanadi Munaf Hussein(Baghdad Medical City), Ghufran jaafar, Alfonso Piciocchi(Fondazione Gimema Onlus), Samaher Fadhil, Wisam Majeed Abed(Baghdad Medical City), Mazin Faisal Al‐Jadiry(University of Baghdad), Maria Luisa Moleti(Sapienza University of Rome), Jawad Sarhan, Sara Mohamed(Royal College of Surgeons in Ireland - Bahrain), Amir Fadhil Al‐Darraji(Baghdad Medical City), Raghad Majid Al‐Saeed(Baghdad Medical City), Hasanein H. Ghali(University of Baghdad), Najiha Ahmed Ameen(Baghdad Medical City), Aseel Rashid Abed(Baghdad Medical City), Robin Foà(Sapienza University of Rome)
Cited by 0
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
|Cytokine|2015|505